原文始发于微信公众号(化学音乐文化):S3C5:Risk Management

JanFourman,PhD, EdD,MBA, MSRA

Eli Lilly – Pharma registration for diabetes/endocrine, women/men’s health, neural science, oncology, bone/muscle/joint therapeutic areas – 5 years
Eli Lilly – Pharmacovigilance – 7 years
Eli Lilly – Regulatory Intelligence – 3 Years
Purdue University and Roche Diagnostics – Teaching global pharma development, Africa and US
Consultant for Indiana Technical Assistance Program
Invited conference speaker
Risk Evaluation and Mitigation Strategies (REMS)
EU Risk Management Plan
FDA Authority for Risk Management
Biologic Risk Management
Sentinel Initiative
发布者:药时代,转载请首先联系contact@drugtimes.cn获得授权